Retrospective Cohort Study of the Effects of NOACs on Postoperative Bleeding Following Dental Extraction

Novel oral anticoagulants (NOACs) are a revolutionary tool to decrease morbidity among patients with a high risk of thromboembolic events. Perioperative management of anticoagulants such as Warfarin have been well studied, but guidelines for perioperative management of patients on NOACs remains controversial. In part, this issue stems from a lack of a standardized and affordable monitoring test, such as an INR (Berton et al, 2019). Studies show that NOACs lead to a bleeding risk synonymous with an INR of 2-4, a moderately safe value for most basic dentoalveolar extractions (Brennan et al, 2020).
Source: Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Authors: Source Type: research